Perspective Therapeutics, Inc.CATXNYSE
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
19.04
↑ 151% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
-36.99
Historical baseline
PeriodValueYoY Change
202519.04+34.6%
202414.15+364.2%
2023-5.36+30.7%
2022-7.73+48.1%
2021-14.88+88.1%
2020-125.28-16.3%
2019-107.73-111.9%
2018-50.84-38.7%
2017-36.66+32.9%
2016-54.60-